document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size font family time roman align center amendment sublicense agreement style margin margin bottom text indent font size font family time roman this amendment sublicense agreement effective november nbsp sublicense agreement made april nbsp between titan pharmaceutical corporation organized under state delaware having principal office oyster point blvd suite south francisco hereinafter titan novartis pharma corporation organized under switzerland having principal office lichtstrasse basel switzerland hereinafter novartis capitalized term used this amendment shall have same meaning forth sublicense agreement style margin margin bottom font size font family time roman align center witnesseth style margin margin bottom text indent font size font family time roman whereas titan novartis desire amend sublicense agreement japan scope sublicense incorporate certain related modification term condition thereof style margin margin bottom text indent font size font family time roman therefore consideration mutual covenant agreement hereinafter forth party hereby agree follows style margin margin bottom text indent font size font family time roman definition section nbsp sublicense agreement hereby deleted entirety replaced with following style margin margin bottom margin left text indent font size font family time roman territory shall mean country territory world provided that country which this sublicense agreement terminated shall removed from scope this definition style margin margin bottom text indent font size font family time roman grant section nbsp hereby deleted entirety replaced with following style margin margin bottom margin left text indent font size font family time roman titan affiliate sublicensees shall entitled utilize patent know field within territory development manufacture compound product marketing distribution sale outside territory those country where novartis right under this sublicense agreement have been terminated style margin margin bottom text indent font size font family time roman payment royalty style margin margin bottom text indent font size font family time roman section nbsp sublicense agreement hereby amended deleting subsection nbsp entirety adding following subsection nbsp style margin margin bottom margin left text indent font size font family time roman upfront license shall paid novartis titan cash within both party execution this amendment agreement additional license shall payable novartis titan within after submission titan style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ertain small small information small small small small been small small omitted small small small small filed small small separately small small with small small small small ommission small small onfidential small small treatment small small small small been small small requested small small with small small respect small small small small small small omitted small small portion small table style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left text indent font size font family time roman novartis invoice time only upon annual sale reaching style margin margin bottom margin left text indent font size font family time roman upon submission titan novartis invoice therefor milestone payment shall payable time only novartis titan follows nbsp shall paid cash upon receipt novartis affiliate sublicensee notification from that product approved novartis affiliate sublicensee their designee schizophrenia other psychiatric disorder nbsp shall paid cash within after receipt such notification payment provided herein shall unless otherwise expressly provided herein refundable style margin margin bottom margin left text indent font size font family time roman novartis shall notify titan writing prior novartis estimated achievement each milestone event described section above upon receipt such notification titan shall send novartis invoice milestone payment result achievement such milestone event novartis shall make each such payment within achievement milestone event which payment style margin margin bottom text indent font size font family time roman section nbsp sublicense agreement hereby deleted entirety replaced with following style margin margin bottom margin left text indent font size font family time roman consideration sublicense granted novartis this sublicense agreement with respect territory novartis shall titan those country where period patent claiming priority date nbsp december nbsp particular country territory which patent been granted validly claiming iloperidone manufacture formulation thereof field exist nbsp percent royalty annual sale product territory nbsp percent royalty annual sale product territory excess each case novartis affiliate sublicensees annual sale product territory style margin margin bottom margin left text indent font size font family time roman consideration sublicense granted novartis this sublicense agreement with respect novartis shall titan nbsp percent royalty annual sale product twenty million dollar nbsp percent royalty annual sale product excess style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ertain small small information small small small small been small small omitted small small small small filed small small separately small small with small small small small ommission small small onfidential small small treatment small small small small been small small requested small small with small small respect small small small small small small omitted small small portion small table style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman each case novartis affiliate sublicensees annual sale product style margin margin bottom text indent font size font family time roman development section nbsp sublicense agreement hereby amended deleting second sentence paragraph style margin margin bottom text indent font size font family time roman exchange information confidentiality section nbsp sublicense agreement hereby amended deleting second sentence paragraph style margin margin bottom text indent font size font family time roman appendix following patent shall added appendix style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom valign bottom align center valign bottom valign bottom align center valign bottom valign bottom align center valign bottom valign bottom align center valign bottom valign bottom align center valign bottom valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom valign bottom align center valign bottom valign bottom align center valign bottom valign bottom align center valign bottom valign bottom valign bottom valign bottom valign bottom valign bottom table style margin margin bottom text indent font size font family time roman effectiveness this amendment shall deemed effective date hereof style margin margin bottom text indent font size font family time roman miscellaneous style margin margin bottom text indent font size font family time roman agreement amended subject provision this section nbsp this amendment shall deemed amendment sublicense agreement reference sublicense agreement other document instrument agreement writing hereafter shall deemed refer sublicense agreement amended hereby style margin margin bottom text indent font size font family time roman successor assigns this amendment shall binding upon inure benefit titan novartis their respective successor assigns style margin margin bottom text indent font size font family time roman governing this amendment shall deemed have been made state york form execution validity construction effect shall determined accordance with state york without regard york other jurisdiction conflict principle style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ertain small small information small small small small been small small omitted small small small small filed small small separately small small with small small small small ommission small small onfidential small small treatment small small small small been small small requested small small with small small respect small small small small small small omitted small small portion small table style page break before always size style color width align center style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman witness whereof party hereby have executed this agreement proper person thereunto duly authorized style font size margin margin bottom nbsp align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width style font family time roman font size valign bottom colspan nowrap novartis pharma style font size height height colspan style font family time roman font size valign valign bottom valign bottom colspan nowrap style margin margin bottom border bottom solid font size font family time roman markus goebel nbsp nbsp nbsp nbsp gisela schelling style font family time roman font size valign name valign bottom valign bottom markus nbsp goebel valign bottom valign bottom nbsp nbsp nbsp nbsp gisela nbsp schelling style font family time roman font size valign title valign bottom valign bottom head nbsp nervous nbsp system valign bottom valign bottom nbsp nbsp nbsp nbsp legal counsel style font family time roman font size valign valign bottom valign bottom valign bottom valign bottom style font size height colspan style font family time roman font size valign colspan titan pharmaceutical style font size height height colspan style font family time roman font size valign valign bottom valign bottom colspan style margin margin bottom border bottom solid font size font family time roman louis bucalo style font family time roman font size valign name valign bottom valign bottom colspan louis bucalo style font family time roman font size valign title valign bottom valign bottom colspan chairman president table body html text document